Data in support of the paper are provided in the Supporting Information. The ultimate data owners of the underlying dataset are the participating hospitals who allowed MMF Systems to deidentify and aggregate relevant patient information. As system access does not prevent access to personal health information, further access can be arranged by contacting the corresponding author.

Introduction {#sec004}
============

Estimates suggest that 20% to 30% of total American healthcare expenditures may be unnecessary. \[[@pone.0133317.ref001]--[@pone.0133317.ref004]\] Over-diagnosis of disease has been described as a modern epidemic in high-income countries.\[[@pone.0133317.ref005]\] A comprehensive review of 146 medical practices found that 40% of those practices recommended when new were reversed upon more rigorous evaluation; some practices were unhelpful, and some were found to substantially increase patient costs without improving outcomes.\[[@pone.0133317.ref006]\]

Recently, there has been a focus on using objective evidence to combat over-diagnosis and over-treatment of disease.\[[@pone.0133317.ref007]\] This strategy is motivated by the need to contain medical costs as mandated by the Affordable Care Act; but, also derives from a sense that there are human as well as economic costs to consider when allocating treatment.\[[@pone.0133317.ref008]\]

Factors that potentially could contribute to higher medical costs include practices that have persisted in medicine and surgery without objective validation of their efficacy. One such practice may be ordering a panel of pre-operative tests that include a prothrombin time (PT) test and/or an activated partial thromboplastin time (aPTT) test prior to surgery to determine whether bleeding is a potential surgical risk.\[[@pone.0133317.ref009]--[@pone.0133317.ref011]\]

We hypothesize that if PT and aPTT tests are used correctly as diagnostic tests (rather than as screening tests), then there should be specific findings on the patient's history and physical (H&P) chart to justify such tests. Further, these indications should be consistent with current guidelines as to when PT and aPTT tests should be ordered. Conversely, if PT and aPTT tests are used for screening, then specific findings in a patient's H&P will not necessarily be present.\[[@pone.0133317.ref012]--[@pone.0133317.ref014]\] Therefore, we compared each patient's PT and/or aPTT results with findings on that patient's H&P to determine whether the tests had been used as diagnostic tests or as screening tests.

Materials and Methods {#sec005}
=====================

We utilized a web-based patient information warehouse and designed a tool for our comparative-effectiveness research. The warehouse is used by hospitals to manage information required for scheduled surgeries that originates with their affiliated surgeons. Our research tool provided us access to de-identified and aggregated patient information through appropriate de-identification provisions (e.g., via hospital service agreements). \[[@pone.0133317.ref015], [@pone.0133317.ref016]\] This research was reviewed and approved by the Rockefeller University Institutional Review Board (MCA-0669) on June 10, 2014.

De-identified pre-surgical patient data (H&Ps and lab reports), generated at 19 hospitals and 8 associated ambulatory surgery centers ([Table 1](#pone.0133317.t001){ref-type="table"}) were aggregated. The time period covered was 48 months (from 2008 through 2012), with the exception of facilities 6, 16, 22, and 27 (data aggregated for 36 months) and facilities 9 and 24 (data aggregated for 46 months).

10.1371/journal.pone.0133317.t001

###### H&P and Lab Data of Patients Who Underwent Surgery.

![](pone.0133317.t001){#pone.0133317.t001g}

  Facility                  Facility Location   Facility Type                Patients                    H&Ps      \%       Labs      \%       H&Ps & Labs   \%       Data Set   \%       
  ------------------------- ------------------- ---------------------------- --------------------------- --------- -------- --------- -------- ------------- -------- ---------- -------- -----
  **Tertiary HospitalsS**   1                   Delaware                     Tertiary Hospital           78,473    62,176   79%       47,738   61%           43,483   55%        62,176   79%
  2                         New Jersey          Tertiary Hospital            23,846                      8,397     35%      19,200    81%      7,325         31%      8,397      35%      
  3                         New Jersey          Tertiary Hospital            40,439                      27,780    69%      20,792    51%      18,579        46%      27,780     69%      
  4                         Maryland            Tertiary Hospital            62,300                      21,639    35%      22,360    36%      13,660        22%      21,639     35%      
  5                         New York            Tertiary Hospital            46,562                      37,201    80%      36,680    79%      33,444        72%      37,201     80%      
  6                         Florida             Tertiary Hospital            14,554                      11,199    77%      11,248    77%      9,726         67%      11,199     77%      
  7                         New Jersey          Tertiary Hospital            41,733                      30,161    72%      20,570    49%      17,163        41%      30,161     72%      
  8                         New Jersey          Tertiary Hospital            62,234                      46,570    75%      38,040    61%      35,028        56%      46,570     75%      
  9                         New York            Tertiary Hospital            55,670                      21,455    39%      15,108    27%      11,326        20%      21,455     39%      
  10                        New Jersey          Tertiary Hospital            29,355                      19,960    68%      19,840    68%      15,752        54%      19,960     68%      
  11                        Pennsylvania        Tertiary Hospital            28,079                      19,023    68%      14,768    53%      13,790        49%      19,023     68%      
  12                        D. of Columbia      Tertiary Hospital            57,865                      35,278    61%      16,877    29%      15,080        26%      35,278     61%      
  13                        Florida             Tertiary Hospital            25,518                      19,590    77%      16,200    63%      15,260        60%      19,590     77%      
  14                        New York            Tertiary Hospital            31,438                      19,596    62%      11,908    38%      11,169        36%      19,596     62%      
  15                        Delaware            Tertiary Hospital            22,859                      17,672    77%      11,230    49%      10,114        44%      17,672     77%      
  16                        New York            Tertiary Hospital            16,804                      12,192    73%      5,129     31%      4,236         25%      12,192     73%      
  17                        New York            Orthopedic Hospital          113,646                     72,806    64%      30,833    27%      24,531        22%      72,806     64%      
  18                        New York            Eye and Ear Hospital         42,311                      33,359    79%      27,955    66%      27,229        64%      33,359     79%      
  19                        Massachusetts       Eye and Ear Hospital         59,407                      53,525    90%      31,094    52%      30,857        52%      53,525     90%      
  Subtotal                                                                   853,079                     569,579   67%      417,570   49%      357,752       42%      569,579    67%      
  **AmbSurg Centers**       20                  Delaware                     Hospital 1 Surgery Center   37,414    28,732   77%       15,497   41%           14,302   38%        28,732   77%
  21                        Maryland            Hospital 4 Surgery Center    26,411                      11,385    43%      9,065     34%      5,968         23%      11,385     43%      
  22                        Florida             Hospital 6 Surgery Center    9,737                       2,539     26%      2,549     26%      1,850         19%      2,539      26%      
  23                        New Jersey          Hospital 8 Surgery Center    27,392                      19,148    70%      9,652     35%      8,509         31%      19,148     70%      
  24                        New York            Hospital 9 Surgery Center    29,469                      12,215    41%      7,286     25%      5,902         20%      12,215     41%      
  25                        New Jersey          Hospital 10 Surgery Center   18,247                      10,123    55%      7,719     42%      6,324         35%      10,123     55%      
  26                        Delaware            Hospital 15 Surgery Center   21,001                      16,377    78%      8,870     42%      8,337         40%      16,377     78%      
  27                        New York            Hospital 16 Surgery Center   30,708                      11,951    39%      3,777     12%      3,054         10%      11,951     39%      
  Subtotal                                                                   200,379                     112,470   56%      64,415    32%      54,246        27%      112,470    56%      
  Total                                                                      1,053,472                   682,049   65%      481,985   46%      411,998       39%      682,049    65%      

The research tool accessed scheduling systems for elective surgery at each hospital. In-patient and emergency room patients who underwent surgeries were not included; such patient information resides on in-house hospital systems, not accessible to the tool. This approach yielded patient information on a consecutive sample of 1,053,472 patients, representing every patient admitted for elective surgery between 2009 and 2012 at all 27 settings, provided that these patients were scheduled, confirmed, and actually underwent surgery (Table A in [S1 File](#pone.0133317.s001){ref-type="supplementary-material"}).

Joint Commission requirements mandate that all hospitals have a recent H&P in place for every patient scheduled for surgery. Therefore, each hospital has an H&P for each patient either in the data warehouse (from its surgeons) or on their own EHR system\[[@pone.0133317.ref017]\] Lab tests are not required for surgery and may not be available on the research tool.

Patient H&P records were evaluated to determine whether there was justification for PT and aPTT testing. Unnecessary tests were defined as PT tests done on patients without a history of: 1) abnormal bleeding, 2) warfarin therapy, 3) vitamin K-dependent clotting factor deficiency, or 4) liver disease; or aPTT tests done on patients without a history of: 1) heparin use, 2) hemophilia, 3) antiphospholipid antibodies (lupus anticoagulant), or 4) von Willebrand disease ([Fig 1](#pone.0133317.g001){ref-type="fig"}).

![H&P Findings That Prompt PT and aPTT Testing.](pone.0133317.g001){#pone.0133317.g001}

Results {#sec006}
=======

Our research tool included 682,049 H&Ps from the 1,053,472 patient records in surgeon EHRs. Thus 65% of patients had H&Ps in our data set ([Table 1](#pone.0133317.t001){ref-type="table"}). The remaining 371,423 H&Ps were in-hospital EHRs and therefore not available for analysis.

Among the 682,049 H&Ps, we found 411,998 associated with PT and aPTT tests (60.4%) ([Fig 2](#pone.0133317.g002){ref-type="fig"}). Some of the remaining 270,051 surgeries may have had associated labs on hospital lab systems that were not accessible to us; therefore, this analysis under-represents the actual ratio of labs to H&Ps. Roughly 39.1% of all potential records (411,998/1,053,472) were evaluated in this study. We cannot assess how many patients received PT and aPTT testing whose records are not available to us.

![Origin of Study Data.](pone.0133317.g002){#pone.0133317.g002}

Roughly 26.2% of all pre-surgical patients accessible in the database received PT tests, of which 94.3% of tests were deemed unnecessary, given the absence of findings on the H&P ([Table 2](#pone.0133317.t002){ref-type="table"}); this means that at least 158,378 unnecessary PT tests were done. Similarly, 23.3% of all pre-surgical patients received aPTT tests, of which 99.9% were deemed unnecessary given an absence of H&P findings ([Table 2](#pone.0133317.t002){ref-type="table"}); this is equivalent to at least 149,484 unnecessary aPTT tests. In most cases, PT and aPTT tests were ordered together ([Fig 3](#pone.0133317.g003){ref-type="fig"}). The PT test was ordered 178,898 times, and the aPTT test was ordered 159,132 times. The tests were ordered together in 157,770 instances. This represents 88.2% of all PT tests ordered, and 99.1% of all aPTT tests ordered. The aPTT test was ordered on its own in only 1362 cases.

![Distribution of PT Only, aPTT Only, and Combined PT/aPTT Tests.](pone.0133317.g003){#pone.0133317.g003}

10.1371/journal.pone.0133317.t002

###### Unnecessary Testing---Where H&Ps Show No Findings.

![](pone.0133317.t002){#pone.0133317.t002g}

  Facility                 Data Set   PT Tests Ordered and % of Data Set   H&Ps Showing no PT Findings (Unnecessary Tests)   aPTT Tests Ordered and % of Data Set   H&Ps Showing no aPTT Findings (Unnecessary Tests)                                        
  ------------------------ ---------- ------------------------------------ ------------------------------------------------- -------------------------------------- --------------------------------------------------- --------- ------- --------- -------- --------
  **Tertiary Hospitals**   1          62,176                               9,881                                             15.9%                                  8,811                                               89.2%     4,240   6.8%      4,238    100.0%
  2                        8,397      4,833                                57.6%                                             4,549                                  94.1%                                               4,753     56.6%   4,751     100.0%   
  3                        27,780     9,913                                35.7%                                             9,255                                  93.4%                                               9,173     33.0%   9,170     100.0%   
  4                        21,639     10,077                               46.6%                                             9,591                                  95.2%                                               8,235     38.1%   8,231     100.0%   
  5                        37,201     29,005                               78.0%                                             28,005                                 96.6%                                               27,376    73.6%   27,366    100.0%   
  6                        11,199     2,707                                24.2%                                             2,459                                  90.8%                                               2,391     21.4%   2,388     99.9%    
  7                        30,161     8,114                                26.9%                                             7,698                                  94.9%                                               7,939     26.3%   7,927     99.8%    
  8                        46,570     11,892                               25.5%                                             10,843                                 91.2%                                               10,441    22.4%   10,433    99.9%    
  9                        21,455     2,283                                10.6%                                             2,020                                  88.5%                                               2,117     9.9%    2,109     99.6%    
  10                       19,960     10,281                               51.5%                                             9,787                                  95.2%                                               9,979     50.0%   9,974     99.9%    
  11                       19,023     3,886                                20.4%                                             3,278                                  84.4%                                               3,790     19.9%   3,787     99.9%    
  12                       35,278     4,983                                14.1%                                             4,701                                  94.3%                                               4,426     12.5%   4,423     99.9%    
  13                       19,590     9,000                                45.9%                                             8,704                                  96.7%                                               8,397     42.9%   8,396     100.0%   
  14                       19,596     7,798                                39.8%                                             7,449                                  95.5%                                               7,384     37.7%   7,380     99.9%    
  15                       17,672     2,096                                11.9%                                             2,008                                  95.8%                                               1,235     7.0%    1,234     99.9%    
  16                       12,192     2,446                                20.1%                                             2,314                                  94.6%                                               2,403     19.7%   2,400     99.9%    
  17                       72,806     12,456                               17.1%                                             12,029                                 96.6%                                               11,983    16.5%   11,958    99.8%    
  18                       33,359     21,285                               63.8%                                             20,729                                 97.4%                                               19,770    59.3%   19,768    100.0%   
  19                       53,525     5,050                                9.4%                                              4,148                                  82.1%                                               3,555     6.6%    3,551     99.9%    
                           569,579    167,986                              29.5%                                             158,378                                94.3%                                               149,587   26.3%   149,484   99.9%    
  **AmbSurg Centers**      20         28,732                               563                                               2.0%                                   510                                                 90.6%     383     1.3%      383      100.0%
  21                       11,385     3,654                                32.1%                                             3,460                                  94.7%                                               2,999     26.3%   2,997     99.9%    
  22                       2,539      243                                  9.6%                                              223                                    91.8%                                               208       8.2%    208       100.0%   
  23                       19,148     1,325                                6.9%                                              1,267                                  95.6%                                               1,136     5.9%    1,136     100.0%   
  24                       12,215     853                                  7.0%                                              787                                    92.3%                                               792       6.5%    788       99.5%    
  25                       10,123     2,919                                28.8%                                             2,776                                  95.1%                                               2,764     27.3%   2,762     99.9%    
  26                       16,377     520                                  3.2%                                              491                                    94.4%                                               458       2.8%    458       100.0%   
  27                       11,951     835                                  7.0%                                              811                                    97.1%                                               805       6.7%    805       100.0%   
  Subtotal                 112,470    10,912                               9.7%                                              10,325                                 94.6%                                               9,545     8.5%    9,537     99.9%    
  Total                    682,049    178,898                              26.2%                                             168,703                                94.3%                                               159,132   23.3%   159,021   99.9%    

There is a wide range between facilities in the frequency with which PT and aPTT tests are ordered. For example, facilities 18 and 19 are both eye and ear specialty hospitals; hospital 18 ordered PT tests for 63.8% of patients, while hospital 19 ordered the same tests for 9.4% of patients.

Across all hospitals and centers, the proportion of unnecessary PT tests ranged from 82.1% to 97.4% and the proportion of unnecessary aPTT tests ranged from 99% to 100% ([Table 2](#pone.0133317.t002){ref-type="table"}). Extrapolating the lowest of these proportions to all patients, some of whom had no H&P records available, enables us to calculate that 90.0% of all patients may have received unnecessary PT tests, and 99.6% of all patients may have received unnecessary aPTT tests ([Table 2](#pone.0133317.t002){ref-type="table"}).

The number and proportion of unnecessary PT and aPTT tests that nevertheless produced abnormal findings is shown ([Fig 4](#pone.0133317.g004){ref-type="fig"}). The rate of abnormal test results was significantly higher in patients with relevant findings on their H&P than in patients with no relevant findings. There were a substantial number of patients for whom unnecessary tests were positive (6.6% and 7.1%). We lack sufficient information to tell whether these results are unanticipated true positives or false positives.

![Abnormal Findings for PT and aPTT Tests.](pone.0133317.g004){#pone.0133317.g004}

The rate of abnormal test results declined with patient age ([Table 3](#pone.0133317.t003){ref-type="table"}). Abnormal PT and aPTT tests were nearly 3-fold more prevalent in patients younger than 30 years than in patients older than 50 years.

10.1371/journal.pone.0133317.t003

###### Age Distribution of Abnormal PT and aPTT Test Rates.

![](pone.0133317.t003){#pone.0133317.t003g}

  ----------------------------- ----------- ----------------------------- ------------------------------- ----------------------------- -------------- ----------- -------------- --------- -------- ------
                                **PT**      **[Tests---Age \<30]{.ul}**   **[Tests---Age 30--50]{.ul}**   **[Tests---Age \>50]{.ul}**                                                                
  **Facility**                  **Tests**   **Total**                     **Abnormal**                    **Total**                     **Abnormal**   **Total**   **Abnormal**                      
  Subtotal Tertiary Hospitals   167,986     13,225                        1,267                           9.6%                          39,426         2,195       5.6%           115,327   13,278   3.7%
  Subtotal AmbSurg              10,912      1,149                         76                              6.6%                          2,545          145         5.7%           7,218     734      1.4%
  Total                         178,898     14,374                        1,343                           9.3%                          41,971         2,340       5.6%           122,545   14,012   3.4%
                                **aPTT**    **[Tests---Age \<30]{.ul}**   **[Tests---Age 30--50]{.ul}**   **[Tests---Age \>50]{.ul}**                                                                
  **Facility**                  **Tests**   **Total**                     **Abnormal**                    **Total**                     **Abnormal**   **Total**   **Abnormal**                      
  Subtotal Tertiary Hospitals   149,587     12,611                        792                             6.3%                          36,603         1,832       5.0%           100,369   8,116    2.3%
  Subtotal AmbSurg              9,545       1,122                         62                              5.5%                          2,331          87          3.7%           6,092     370      0.7%
  Total                         159,132     13,733                        854                             6.2%                          38,934         1,919       4.9%           106,461   8,486    2.1%
  ----------------------------- ----------- ----------------------------- ------------------------------- ----------------------------- -------------- ----------- -------------- --------- -------- ------

Statistical Analysis {#sec007}
--------------------

We tested a hypothesis that the percentage of abnormal results on both the PT and aPTT tests is the same ([Fig 5](#pone.0133317.g005){ref-type="fig"}). This hypothesis was rejected, the p-value being practically 0. The 95% confidence intervals (PT: 6.48--6.72) and (aPTT: 6.97--7.23) were non-overlapping, indicating that the proportion of false positives on PT and aPTT tests are independent of one another. This suggests that patients who get a false positive on one test are not more likely to get an abnormal result on the other test.

![Statistical Overview.](pone.0133317.g005){#pone.0133317.g005}

Similarly, a χ^2^ test was used to test the hypothesis that the PT and aPTT tests were used independently. The fourfold contingency table (see [Table 4](#pone.0133317.t004){ref-type="table"} and [Fig 2](#pone.0133317.g002){ref-type="fig"}) for the two tests shows that this hypothesis can be rejected (again the p-value being practically 0), suggesting that physicians tend to order both tests together. This is also evident from the large number of patients who were given both tests or neither test ([Table 4](#pone.0133317.t004){ref-type="table"}).

10.1371/journal.pone.0133317.t004

###### Fourfold Contingency Table.

![](pone.0133317.t004){#pone.0133317.t004g}

                                                                                      PT T[est]{.smallcaps} O[rdered]{.smallcaps}   PT T[est]{.smallcaps} N[ot]{.smallcaps} O[rdered]{.smallcaps}   T[otal]{.smallcaps}
  ----------------------------------------------------------------------------------- --------------------------------------------- --------------------------------------------------------------- ---------------------
  **[a]{.smallcaps}PTT T[est]{.smallcaps} O[rdered]{.smallcaps}**                     157,770                                       1,362                                                           159,132
  **[a]{.smallcaps}PTT T[est]{.smallcaps} N[ot]{.smallcaps} O[rdered]{.smallcaps}**   21,128                                        501,789                                                         522,917
  **T[otal]{.smallcaps}**                                                             178,898                                       503,151                                                         682,049

Discussion {#sec008}
==========

We have demonstrated that 94.3% of all PT tests and 99.9% of all aPTT tests in our data set were ordered without documented justification in patient H&Ps. Our results clearly show that both PT and aPTT tests are routinely used as screening tests ([Table 2](#pone.0133317.t002){ref-type="table"}), although no rationale exists to conclude that these tests are anything other than diagnostic.

Unnecessary PT tests may actually comprise 97.6% rather than 94.3% ([Fig 4](#pone.0133317.g004){ref-type="fig"}) if the data is adjusted to eliminate patients on warfarin whose tests were ordered too early (typically patients should be off warfarin therapy five days prior to surgery allowing PT levels to normalize and tested within 24--48 h of surgery to confirm the patient has stopped warfarin therapy). \[[@pone.0133317.ref018]\]

Though it is well known that these tests are often ordered with no clinical justification, we have shown that this practice of ordering these tests is widespread, at least in the surgical environment.\[[@pone.0133317.ref019]\] If extrapolated on a national and international level, the scope of unnecessary testing could be significant as well as the direct and indirect healthcare costs and burdens. For instance, the CDC estimates that in the US, there are over 50 million surgical patients operated on annually. \[[@pone.0133317.ref020], [@pone.0133317.ref021]\]

Given the extent to which surgeons order PT and aPTT tests, they must believe that results are important in predicting bleeding complications. The following two questions provide a better perspective regarding these tests.

1.  How useful are the tests in predicting bleeding complications?

2.  Does an abnormal test result represent a false positives or a true positive?

How useful are the tests in predicting bleeding complications?\[[@pone.0133317.ref022]\] The PT test was introduced in 1935 for the management of warfarin therapy\[[@pone.0133317.ref023]\], while the aPTT test was introduced in 1953 and became the test of choice for the management of heparin therapy.\[[@pone.0133317.ref024]\] Both tests are useful when employed for their intended purposes. However, under most circumstances, even if there is an H&P finding that suggests a need for testing, it is still unlikely that the patient will have a prolonged PT or aPTT as well as a meaningful bleeding complication, since most of the findings on an H&P (disseminated intravascular coagulation, liver disease\[[@pone.0133317.ref025]\], vitamin K deficiency, congenital factor VII deficiency\[[@pone.0133317.ref026]\], dysfibrinogenemia\[[@pone.0133317.ref027]\], factors XII, XI, IX, and VII, lupus anticoagulant, and von Willebrand disease\[[@pone.0133317.ref028]--[@pone.0133317.ref030]\]) must be quite advanced, and these patients would already have been identified. Accordingly, in contrast with the eight H&P findings commonly used by physicians, the literature only supports the use of these tests where the patient is utilizing warfarin or heparin. Further, near-unanimous results from peer reviewed publications have demonstrated that abnormalities on coagulation tests are not predictive of bleeding events.\[[@pone.0133317.ref031]--[@pone.0133317.ref039]\]

Does an abnormal test result represent a false positives or a true positive? Abnormal test results in the absence of H&P findings were observed at rates of 6.6% for PT tests and 7.1% for aPTT tests ([Fig 4](#pone.0133317.g004){ref-type="fig"}). These findings may be false positives or true positives (i.e. potential bleeding complication in a patient about to undergo surgery). It has been shown that the prevalence of asymptomatic coagulopathies is so low that false-positive test results greatly outnumber true-positive results.\[[@pone.0133317.ref040]\] Accordingly, an abnormal test result is most likely a false positive for one or more of the following reasons\[[@pone.0133317.ref041]\]: Inadequate determination of reference standards (reagents and instrumentation)\[[@pone.0133317.ref042]\];High patient hematocrit resulting in an artifactual prolongation of the clotting time\[[@pone.0133317.ref043]\];Variations in citrate anticoagulant (3.2% or 3.8%), which is known to affect results\[[@pone.0133317.ref044]\];Fasting state of the patient (plasma turbidity can interfere with optical systems in non-fasting lipemic, hemolyzed, or icteric specimens)\[[@pone.0133317.ref045]\];PT tests should be done within 24 h of collection, and aPTT should be determined within 4 h, especially if the sample is heparinized.\[[@pone.0133317.ref046]\]

Some weaknesses of the present study may limit the scope of our conclusions. First, our study tool could not access all H&P and lab information from the various sites. Patient information was received from some hospital surgeons who did not utilize the hospital's in-house EMR and/or lab systems; these patients may constitute a different patient population than other patients in the hospitals studied here. Second, the Joint Commission mandates that an H&P exist for each surgery undertaken. Therefore, the study tool should have had access to an H&P for each of the 1,053,472 surgeries. In contrast, we had access to only 65% of these H&Ps, because all other H&Ps were on hospital systems that were not accessible to our tool. The research tool also had access to only some labs, which underrepresents the actual ratio of H&Ps to labs ([Fig 1](#pone.0133317.g001){ref-type="fig"}). Third, on a geographic basis, our sample reflects surgeon ordering practices compiled from data from seven states and the District of Columbia, which may or may not be representative of surgeon ordering practices in the unevaluated portion of the United States. Fourth, the study did not include pregnancy morbidity as an indicator, which is relevant to diagnosing antiphospholipid syndrome (APS) and a potential factor prompting PT and aPTT testing and unexplained thrombosis.

Since a meaningful percentage of surgeons use these tests as screening tests (*88*.*2% of PT tests and 99*.*1% of aPTT tests*) it would appear these tests are being ordered by surgeons as part of their routine pre-surgical process. Accordingly, given the previously mentioned cost burdens, consideration by the relevant industry constituencies could be given to exploring the use of change agents to evolve these apparent pre-surgical processes to conform with evidence-based practices. Some hospitals appear to be proactive in reducing unnecessary testing (*e.g., [Table 2](#pone.0133317.t002){ref-type="table"}: facility 19 vs. facility 18, both specialty eye and ear hospitals*). Our data reflect substantially lower levels of unnecessary testing at some hospitals. For example, one hospital performed roughly 15% as many tests as a comparable hospital with similar surgery cases. The burdens and costs of unnecessary testing may not only refer to the test per se, but also extend to the follow-on professional obligations placed on health-care professionals.

Conclusions {#sec009}
===========

We report what we believe to be the largest prospective sample of surgical patients ever assembled. Our sample includes 1,053,472 consecutive patients from 27 medical facilities enrolled from 2009 to 2012, and we were able to gather complete data for a subset of 65% of those patients (N = 682,049). Our results show that both PT and aPTT are used as screening tests, though no rationale exists to conclude that these tests are anything other than diagnostic. Overall, 26.2% of patients received PT testing, and 94.3% of those tests were not necessary, given the absence of findings on the patient H&P. Similarly, 23.3% of preoperative patients received aPTT testing, of which 99.9% of tests were unnecessary. For patients with no H&P findings suggestive of bleeding risk, 6.6% of PT tests and 7.1% of aPTT tests were positive, indicating either a false positive or an unanticipated true positive finding. Given that bleeding conditions are likely to be diagnosed symptomatically prior to surgery, most positive findings are likely to be false positives.

We therefore document routine pre-surgical practices for which there is no clinical justification and which can put patients at risk of false-positive findings. Useless tests are clinically inappropriate because they consume resources, yet bring no benefit to patients or clinicians. Empty testing is also ethically wrong, because it puts patients at risk to no purpose. If our study set is representative of national practices in the United States, then modification of current testing practices could substantially reduce the number of unnecessary PT and aPTT tests, thereby saving hospitals, the Centers for Medicare and Medicaid Services, and insurance companies the costs of unnecessary testing. Our tool offers an unprecedented window into unnecessary testing in the United States.
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